• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

具有雌激素和孕激素受体的人卵巢癌细胞系的特征分析

Characterization of a human ovarian carcinoma cell line with estrogen and progesterone receptors.

作者信息

Geisinger K R, Kute T E, Pettenati M J, Welander C E, Dennard Y, Collins L A, Berens M E

机构信息

Department of Pathology, Wake Forest University, Bowman Gray School of Medicine, Winston-Salem, North Carolina 27103.

出版信息

Cancer. 1989 Jan 15;63(2):280-8. doi: 10.1002/1097-0142(19890115)63:2<280::aid-cncr2820630213>3.0.co;2-n.

DOI:10.1002/1097-0142(19890115)63:2<280::aid-cncr2820630213>3.0.co;2-n
PMID:2910432
Abstract

The potential significant therapeutic and prognostic roles for the sex steroid receptors in ovarian cancer are recognized. The authors present in detail the biochemical, morphologic, cytogenetic, and growth characteristics of an ovarian carcinoma cell line, BG-1, which has functional estrogen and progesterone receptors (23 and 300 fmol/mg protein, respectively) in clinically significant levels. In particular, BG-1 has a DNA index of 1.14, a stable karyotype with specific translocations, and produces and secretes CA 125 into the media.

摘要

性类固醇受体在卵巢癌中潜在的重要治疗和预后作用已得到认可。作者详细介绍了一种卵巢癌细胞系BG-1的生化、形态学、细胞遗传学和生长特征,该细胞系具有临床上显著水平的功能性雌激素和孕激素受体(分别为23和300 fmol/mg蛋白)。特别是,BG-1的DNA指数为1.14,具有特定易位的稳定核型,并在培养基中产生和分泌CA 125。

相似文献

1
Characterization of a human ovarian carcinoma cell line with estrogen and progesterone receptors.具有雌激素和孕激素受体的人卵巢癌细胞系的特征分析
Cancer. 1989 Jan 15;63(2):280-8. doi: 10.1002/1097-0142(19890115)63:2<280::aid-cncr2820630213>3.0.co;2-n.
2
Estrogen and progesterone receptors in human ovarian tumors.
Gynecol Oncol. 1983 Oct;16(2):246-53. doi: 10.1016/0090-8258(83)90099-9.
3
[Estrogen and progesterone receptors in ovarian carcinoma].
Jugosl Ginekol Perinatol. 1985 Jan-Apr;25(1-2):13-6.
4
DNA profile and steroid receptor content of human ovarian cancer.
Eur J Gynaecol Oncol. 1988;9(6):461-3.
5
Ovarian carcinoma: histologic and clinical correlation of cytoplasmic estrogen and progesterone binding.
Gynecol Oncol. 1981 Dec;12(3):319-27. doi: 10.1016/0090-8258(81)90132-3.
6
[Estrogen and progesterone receptors in human ovary and ovarian tumors].
Hua Xi Yi Ke Da Xue Xue Bao. 1989 Sep;20(3):253-6.
7
Clinical evaluation of steroid receptors in ovarian neoplasms.
Int J Gynaecol Obstet. 1987 Apr;25(2):145-9. doi: 10.1016/0020-7292(87)90009-9.
8
Phenotypic characterization, karyotype analysis and in vitro tamoxifen sensitivity of new ER-negative vulvar carcinoma cell lines, UM-SCV-1A and UM-SCV-1B.新的雌激素受体阴性外阴癌细胞系UM-SCV-1A和UM-SCV-1B的表型特征、核型分析及体外他莫昔芬敏感性
Int J Cancer. 1990 May 15;45(5):920-7. doi: 10.1002/ijc.2910450524.
9
[Endocrinal studies of DMBA-induced ovarian cancer--detection of progesterone receptor and morphologic changes following progesterone application].
Nihon Gan Chiryo Gakkai Shi. 1983 Oct 20;18(7):1873-82.
10
Steroid receptors and progestinic therapy in ovarian endometrioid carcinoma.
Eur J Gynaecol Oncol. 1982;3(3):241-6.

引用本文的文献

1
P-cadherin overexpression is associated with early transformation of the Fallopian tube epithelium and aggressiveness of tubo-ovarian high-grade serous carcinoma.P-钙黏蛋白过表达与输卵管上皮的早期转化及输卵管卵巢高级别浆液性癌的侵袭性相关。
Virchows Arch. 2025 May 5. doi: 10.1007/s00428-025-04104-7.
2
The SHDRA syndrome-associated gene encodes a protein-specific O-mannosyltransferase.SHDRA 综合征相关基因编码一种蛋白特异性 O-甘露糖基转移酶。
Proc Natl Acad Sci U S A. 2023 May 23;120(21):e2302584120. doi: 10.1073/pnas.2302584120. Epub 2023 May 15.
3
Glycogen synthase kinase-3 beta (GSK3β)-mediated phosphorylation of ETS1 promotes progression of ovarian carcinoma.
糖原合酶激酶-3β(GSK3β)介导的 ETS1 磷酸化促进卵巢癌的进展。
Aging (Albany NY). 2021 May 23;13(10):13739-13763. doi: 10.18632/aging.202966.
4
Marine Collagen Substrates for 2D and 3D Ovarian Cancer Cell Systems.用于二维和三维卵巢癌细胞系统的海洋胶原蛋白基质
Front Bioeng Biotechnol. 2019 Dec 13;7:343. doi: 10.3389/fbioe.2019.00343. eCollection 2019.
5
Pro-apoptotic and anti-angiogenic actions of 2-methoxyestradiol and docosahexaenoic acid, the biologically derived active compounds from flaxseed diet, in preventing ovarian cancer.亚麻木酚素和二十二碳六烯酸(来源于亚麻籽的生物活性化合物)通过促进细胞凋亡和抑制血管生成预防卵巢癌。
J Ovarian Res. 2019 May 25;12(1):49. doi: 10.1186/s13048-019-0523-3.
6
MAST1 Drives Cisplatin Resistance in Human Cancers by Rewiring cRaf-Independent MEK Activation.MAST1 通过重排 cRaf 非依赖性 MEK 激活驱动人类癌症中的顺铂耐药性。
Cancer Cell. 2018 Aug 13;34(2):315-330.e7. doi: 10.1016/j.ccell.2018.06.012. Epub 2018 Jul 19.
7
METCAM/MUC18 is a novel tumor and metastasis suppressor for the human ovarian cancer SKOV3 cells.METCAM/MUC18是一种针对人卵巢癌细胞SKOV3的新型肿瘤和转移抑制因子。
BMC Cancer. 2016 Feb 22;16:136. doi: 10.1186/s12885-016-2181-9.
8
MAPK Activation Predicts Poor Outcome and the MEK Inhibitor, Selumetinib, Reverses Antiestrogen Resistance in ER-Positive High-Grade Serous Ovarian Cancer.丝裂原活化蛋白激酶(MAPK)激活预示不良预后,且MEK抑制剂司美替尼可逆转雌激素受体阳性高级别浆液性卵巢癌中的抗雌激素耐药性。
Clin Cancer Res. 2016 Feb 15;22(4):935-47. doi: 10.1158/1078-0432.CCR-15-0534. Epub 2015 Oct 19.
9
Research Resource: STR DNA profile and gene expression comparisons of human BG-1 cells and a BG-1/MCF-7 clonal variant.研究资源:人BG-1细胞与BG-1/MCF-7克隆变体的STR DNA谱及基因表达比较
Mol Endocrinol. 2014 Dec;28(12):2072-81. doi: 10.1210/me.2014-1229.
10
A 3D fibrous scaffold inducing tumoroids: a platform for anticancer drug development.一种诱导肿瘤球的 3D 纤维支架:用于抗癌药物开发的平台。
PLoS One. 2013 Oct 16;8(10):e75345. doi: 10.1371/journal.pone.0075345. eCollection 2013.